Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania ; volume:12 ; number:1 ; day:18 ; month:3 ; year:2013 ; pages:1-7 ; date:12.2013
Malaria journal ; 12, Heft 1 (18.3.2013), 1-7, 12.2013
- Creator
-
Malmberg, Maja
- Contributor
-
Ngasala, Billy
Ferreira, Pedro E.
Larsson, Erik
Jovel, Irina
Hjalmarsson, Angelica
Petzold, Max
Premji, Zul
Gil, José P.
Björkman, Anders
Mårtensson, Andreas
SpringerLink (Online service)
- DOI
-
10.1186/1475-2875-12-103
- URN
-
urn:nbn:de:1111-2016080642359
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Malmberg, Maja
- Ngasala, Billy
- Ferreira, Pedro E.
- Larsson, Erik
- Jovel, Irina
- Hjalmarsson, Angelica
- Petzold, Max
- Premji, Zul
- Gil, José P.
- Björkman, Anders
- Mårtensson, Andreas
- SpringerLink (Online service)
Other Objects (12)
Electrocardiographic safety evaluation of extended artemether-lumefantrine treatment in patients with uncomplicated Plasmodium falciparum malaria in Bagamoyo District, Tanzania
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
The clinical efficacy of artemether/lumefantrine (Coartem®)
Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania
Artemether–lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2018
Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2019
Usefulness of day 7 lumefantrine plasma concentration as a predictor of malaria treatment outcome in under-fives children treated with artemether-lumefantrine in Tanzania
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi
Malaria case-management under artemether-lumefantrine treatment policy in Uganda
Does artemether–lumefantrine administration affect mosquito olfactory behaviour and fitness?
Electrocardiographic safety evaluation of extended artemether-lumefantrine treatment in patients with uncomplicated Plasmodium falciparum malaria in Bagamoyo District, Tanzania
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
The clinical efficacy of artemether/lumefantrine (Coartem®)
Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania
Artemether–lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2018
Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2019
Usefulness of day 7 lumefantrine plasma concentration as a predictor of malaria treatment outcome in under-fives children treated with artemether-lumefantrine in Tanzania
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi
Malaria case-management under artemether-lumefantrine treatment policy in Uganda
Does artemether–lumefantrine administration affect mosquito olfactory behaviour and fitness?
Electrocardiographic safety evaluation of extended artemether-lumefantrine treatment in patients with uncomplicated Plasmodium falciparum malaria in Bagamoyo District, Tanzania
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
The clinical efficacy of artemether/lumefantrine (Coartem®)
Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania
Artemether–lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2018
Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2019
Usefulness of day 7 lumefantrine plasma concentration as a predictor of malaria treatment outcome in under-fives children treated with artemether-lumefantrine in Tanzania
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi
Malaria case-management under artemether-lumefantrine treatment policy in Uganda